Geisinger Cancer Institute combines advanced cancer care, precision medicine and leading research to improve outcomes and expand access to innovative therapies for our communities.

As an NCI-designated Community Oncology Research Program (NCORP) site, we connect you and your patients to nearly 100 national Phase II and III clinical trials — no referral to a distant academic center required.

And our multidisciplinary teams leverage insights from the MyCode^® Community Health Initiative, one of the world's largest healthcare-based genomic research programs, to support more personalized treatment decisions.

Through advanced technologies, including the region's only CyberKnife^® S7 robotic radiation system, groundbreaking immunotherapy research and strong partnerships with referring providers, we’re helping shape the future of cancer care.